EP Biocomposites Ltd
₹ 116
-9.90%
11 Jun
- close price
About
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions[1]
Key Points
- Market Cap ₹ 19.5 Cr.
- Current Price ₹ 116
- High / Low ₹ 230 / 105
- Stock P/E 19.0
- Book Value ₹ 63.0
- Dividend Yield 0.00 %
- ROCE 14.2 %
- ROE 10.2 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.4% over last 3 years.
- Company has high debtors of 330 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2020 3m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
0.57 | 2.95 | 8.06 | 7.12 | 11.43 | 12.01 | |
0.53 | 2.49 | 6.66 | 6.15 | 10.02 | 10.24 | |
Operating Profit | 0.04 | 0.46 | 1.40 | 0.97 | 1.41 | 1.77 |
OPM % | 7.02% | 15.59% | 17.37% | 13.62% | 12.34% | 14.74% |
0.00 | 0.00 | 0.02 | 0.17 | 0.30 | 0.11 | |
Interest | 0.00 | 0.00 | 0.19 | 0.23 | 0.04 | 0.35 |
Depreciation | 0.00 | 0.00 | 0.07 | 0.10 | 0.10 | 0.11 |
Profit before tax | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 |
Tax % | 25.00% | 23.91% | 31.03% | 28.40% | 26.75% | 27.46% |
0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | |
EPS in Rs | 6.00 | 72.00 | 6.88 | 3.45 | 6.84 | 6.13 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 84% |
3 Years: | 14% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 103% |
3 Years: | 8% |
TTM: | -10% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -30% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 11% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 |
Reserves | -0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 |
0.00 | 0.00 | 4.11 | 1.28 | 1.80 | 2.98 | |
0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | |
Total Liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 |
0.00 | 0.00 | 0.41 | 0.33 | 0.33 | 0.23 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.14 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | |
Total Assets | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
0.12 | 0.03 | -4.28 | -0.79 | -1.24 | -0.49 | |
0.00 | 0.00 | -0.47 | 0.02 | -0.16 | 0.02 | |
0.00 | 0.00 | 4.76 | 2.81 | 0.49 | 0.82 | |
Net Cash Flow | 0.12 | 0.03 | 0.01 | 2.04 | -0.92 | 0.35 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 192.11 | 80.42 | 321.53 | 300.41 | 287.40 | 330.05 |
Inventory Days | 83.65 | 90.25 | 86.83 | 90.58 | 53.86 | 66.66 |
Days Payable | 349.79 | 128.35 | 161.90 | 104.79 | 153.74 | 97.87 |
Cash Conversion Cycle | -74.04 | 42.32 | 246.47 | 286.20 | 187.52 | 298.85 |
Working Capital Days | -57.63 | 25.98 | 244.54 | 259.91 | 239.82 | 286.89 |
ROCE % | 219.05% | 41.54% | 13.16% | 15.30% | 14.20% |
Documents
Announcements
-
Integrated Filing (Financial)
23 May - EP Biocomposites reports audited FY25 financials; revenue Rs 1200.62L, profit Rs 141.70L, IPO proceeds fully utilized.
-
Board Meeting Outcome for Half Yearly And Year To Date Results Of The Company For The Half Year Ended March 31, 2025
23 May - EP Biocomposites reports audited FY25 financials; revenue Rs 1200.62L, profit Rs 141.70L, IPO proceeds fully utilized.
-
Board Meeting Intimation for Consideration Of The Financial Results For The Year Ended March 31, 2025
20 May - Board meeting on May 23, 2025, to approve FY25 draft results; trading window closed as per regulations.
-
Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
30 Apr - CEO Anand Menon resigns effective Nov 14, 2024 citing personal reasons; resignation letter attached.
-
Closure of Trading Window
1 Apr - Closure of trading window for earnings release.
Business Overview:[1]
a) EPBL is a flagship entity of EP Kamat
Group.
b) It manufactures and supplies Fibre
Reinforced Polymers (FRP) products
such as Door Shutters, Frames, Laminated
Doors, Biodigester Tanks, Bio Toilets and
Allied Products for Construction and Industrial applications
c) Company has an Aqua Division which offers Sewage & Effluent Treatment Plants for Hotels, Industry, Institutions, Government bodies as well as residential and commercial buildings
d) In FY24, company has added the line
of Fire doors to its portfolio